Evidence map›Paper›PMID 35457949›Full record

ArticleNanomaterials (Basel, Switzerland)2022

Manifestations of Laser-Induced Graphene under Ultraviolet Irradiation of Polyimide with Varied Optical Fluence.

Ilija R Hristovski, Luke A Herman, Michael E Mitchell, Nikolai I Lesack, Jason Reich, Jonathan F Holzman

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ilija R HristovskiIntegrated Optics Laboratory, School of Engineering, University of British Columbia, Kelowna, BC V1V 1V7, Canada.ORCID 0000-0001-5386-6076
Luke A HermanIntegrated Optics Laboratory, School of Engineering, University of British Columbia, Kelowna, BC V1V 1V7, Canada.ORCID 0000-0001-7198-4527
Michael E MitchellIntegrated Optics Laboratory, School of Engineering, University of British Columbia, Kelowna, BC V1V 1V7, Canada.
Nikolai I LesackIntegrated Optics Laboratory, School of Engineering, University of British Columbia, Kelowna, BC V1V 1V7, Canada.
Jason ReichIntegrated Optics Laboratory, School of Engineering, University of British Columbia, Kelowna, BC V1V 1V7, Canada.ORCID 0000-0002-9212-7791
Jonathan F HolzmanIntegrated Optics Laboratory, School of Engineering, University of British Columbia, Kelowna, BC V1V 1V7, Canada.

Funding

Canada Foundation for Innovation LOF 16659Natural Sciences and Engineering Research Council RGPIN-2017-04073Western Economic Diversification Canada NA
6 · The paper itself

Abstract

In this work, we put forward a rigorous study on ultraviolet (355-nm) laser irradiation of polyimide for the realization of high-quality laser-induced graphene (LIG) with micron-scale features. High-quality material and micron-scale features are desirable-but often at odds-given that small features demand tightly focused beam spots, with a predisposition to ablation. As such, we investigate the synthesis of LIG by correlating the material characteristics, as gleaned from scanning electron microscopy and Raman spectroscopy, to the incident optical fluence, as a measure of applied optical energy per unit area. The study reveals that high-quality LIG, with ratios of Raman 2D-to-G peak heights approaching 0.7, can be synthesized with micron-scale features, down to 18 ± 2 μm, given suitable attention to the optical fluence. Optimal characteristics are seen at optical fluences between 40 and 50 J/cm

Indexed as

graphenelaser-induced grapheneoptical fluenceRaman spectroscopy

Identifiers

PMID35457949
PMCPMC9025711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.